跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ANDEMBRY 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ANDEMBRY 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
Approved
STANDARD
ANDEMBRY 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
Csl Behring Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 9, 2025
Approval ID
f15a00fba6dda70c
Company
Csl Behring Gmbh
Type
Standard
Approval Details
Approval Id
f15a00fba6dda70c
Drug Cima Aemps Name
ANDEMBRY 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA
Register Number
1241885003
Holder Company Name
Csl Behring Gmbh
Marketing Company Name
Csl Behring S.A.
Holder Company Detail Path
/organization/csl-behring-gmbh
Authorization Date
2025-04-09
Dosage Form
SOLUCIÓN INYECTABLE
Dose
200 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Csl Behring Gmbh
Company Detail Path
/organization/csl-behring-gmbh
Company Information
Pharmaceutical Company Name
Csl Behring Gmbh
Country Name
Germany
Website
http://www.cslbehring.de
Active Ingredients
GARADACIMAB
200 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 9, 2025
Approval ID
f15a00fba6dda70c
Type
Standard
Back to CIMA-AEMPS Approvals